Sanara MedTech (SMTI) Depreciation & Amortization (CF) (2010 - 2026)

Sanara MedTech has reported Depreciation & Amortization (CF) for 16 years, with the latest figure at $587252.0 in Q1 2026.

• For the quarter ending Q1 2026, Depreciation & Amortization (CF) fell 47.77% year-over-year to $587252.0; the trailing twelve-month figure through Mar 2026 stood at $3.4 million (down 31.03% YoY), and the FY2025 full-year result was $3.9 million, down 19.85% from the prior year.
• Depreciation & Amortization (CF) for Q1 2026 stood at $587252.0, down from $668396.0 in the prior quarter.
• The five-year high for Depreciation & Amortization (CF) was $1.6 million in Q4 2024, with the low at $202747.0 in Q1 2022.
• Historically, Depreciation & Amortization (CF) has averaged $911913.8 across 5 years, with a median of $997674.0 in 2023.
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 434.81% — and 2025, when it plunged 58.44%.
• Sanara MedTech's Depreciation & Amortization (CF) stood at $814316.0 in 2022, then surged by 34.44% to $1.1 million in 2023, then surged by 46.92% to $1.6 million in 2024, then sank by 58.44% to $668396.0 in 2025, then dropped by 12.14% to $587252.0 in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $587252.0 (Q1 2026), $668396.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.